<DOC>
	<DOCNO>NCT00669123</DOCNO>
	<brief_summary>The purpouse study determine efficacy safety chondroitin sulphate conventional treatment patient knee osteoarthritis plaque psoriasis .</brief_summary>
	<brief_title>Chondroitin Sulphate Efficay/Safety Patients With Knee Osteoarthritis Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<criteria>Primary knee OA accord ACR criterion ; OA radiological stage 1 3 accord KellgrenLawrence ; VAS pain ≥30 ; PASI ≥ 5 . Known allergy chondroitin sulphate ; Other bone articular disease chondrocalcinosis , Paget 's disease , rheumatoid arthritis , psoriatic arthritis , acromegaly , hemochromatosis , Wilson 's disease ; Patients skin condition could interfere clinical trial evaluation</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Chondroitin sulphate</keyword>
	<keyword>Knee osteoarthritis</keyword>
	<keyword>Psoriasis</keyword>
</DOC>